RSS Feeds
Search

Companies

APR Applied Pharma Research S.A.

APR Applied Pharma Research S.A.
APR is a private, independent, integrated Healhcare Company focused on Delivering, Funding and Supporting Innovation in Healthcare.

The company in detail

Profile

APR Applied Pharma Research s.a. is an independent, international and integrated Healthcare Company headquartered in Switzerland and focused on three major areas: Delivering, Funding and Supporting Innovation in Healthcare.

In particular, APR develops and licenses innovative, value added and patented healthcare products and proprietary drug delivery systems primarily in the oral and topical fields;

APR also invests in companies or early stage innovative projects and provides a balanced mix of equity funding and/or financing together with APR’s development, scientific, technical, marketing, licensing and management skills and know how;

finally, APR supports biotech and pharmaceutical companies in the development of new pharmaceutical projects by providing on a contract basis added value, consultancy and R&D services under contract using a General Contractor approach.
APR has entered into licensing and partnership agreements with pharmaceutical companies in over 100 countries worldwide with international sales on a worldwide basis.

Partnering strategy/interests

APR is interested to evaluate any partnering opportunity with drug discovery as well as drug delivery companies focused in oral and topical products and interested to join forces and boost product development of new innovative drugs.

APR is also interested to evaluate in-licensing opportunities of promising early stage drug candidates in the oral, topical and transdermal areas.

Out-licensing

12,5 mg diclofenac K film coated immediate release tablets (OTC) More
Zolmitripan Oral Dispersible Film (ODF) is a a novel, non-mucoadhesive, fast dissolving oral dosage form of Zolmitriptan More
4 and 8 mg Ondansetron ready for submission in EU (exp. Q4/08) using the proprietary RapidFilm drug delivery Technology securing fast dissolution in the oral cavity without the need of water More
5 and 10 mg Donepezil are under final development using the proprietary RapidFilm drug delivery Technology securing fast dissolution in the oral cavity without the need of water More
Biotechnology Product for Wound Healing More
The First Line of Therapy in Severe Migraine Attacks More
Adhesive patch containing and delivering essential and balsamic oils for the symptomatic treatment of the common cold and nasal congestion More
25 and 50 mg diclofenac K film coated immediate release tablets More
The first pure, immediate release (Tmax in 13,68 min), completely palatable and free from aftertaste diclofenac potassium formulation in drops at 5% available on the market More
25mg dosage strenght for the OTC market More
25mg dosage strenght for the OTC market in film coated tablets More
Innovative chewable tablets iron based More
Adhesive Patch of 90 sq. cm. and containing as active ingredient 100 mg. of ketoprofen for the local treatment of traumatic injuries and extra-articular rheumatism More
Multilayered controlled release oral solid pharmaceutical composition in tablet form suitable for oral administration comprising at least two layers containing active material in association with excipients and additives. More
RapidFilm: The solution for dissolving oral doses More
New pharmaceutical compositions for oral use containing diclofenac together with alkali metal carbonates and bicarbonates and particular flavouring substances. More

In-licensing

APR is interested to in-license new early stage, innovative and patent protected products/technologies (preferably off patent or close to expiry) for oral, topical or transdermal administration More

Contact details

Mr Paolo Galfetti
CEO

Contact directly

Full contact list

Head office

APR Applied Pharma Research S.A.
Via Corti 5
Balerna
6828
Switzerland

Full offices list

Company figures

Formed: 1990
Annual Turnover: 10'000'000 (2009)
Number of employees: 31

Related categories

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2014 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us